People with a condition in which protein build up stiffens heart walls – called transthyretin amyloid cardiomyopathy – were more likely to have a stroke if they also had a mechanical malfunction in ...

Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to ...

A retrospective study of 75 heart failure patients found that Impella 5.5 support was associated with significant reductions in pulmonary vascular resistance and pulmonary artery pressures before ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to heart pump treatments and are left with only medication or palliative care.

There are new and revised warnings about the instructions for use of a certain type of heart pump that could lead to a risk of heart perforation, according to an alert issued by the pump’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson's Impella CP heart pump in an illustration of the heart. Johnson & Johnson's Impella heart pump failed to lower ...

Magenta Medical, the developer of Elevate (the world’s smallest heart pump), announced it had closed a $105 million funding round led by global healthcare investment firm Novo Holdings. The new ...

Walking and stair climbing are two popular forms of cardiovascular exercise, both offering unique benefits for heart health ...

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart ...

A total of 58% of people implanted with HeartMate 3 lived at least five years after placement, compared to 44% of HeartMate II patients, according to results of Abbott’s Momentum 3 clinical trial.